SCHEDULE 13G/A: Brandes Investment Partners Discloses 10.48% Stake in Phibro Animal Health

Brandes Investment Partners, along with affiliated entities and Glenn Carlson, has filed an amended Schedule 13G, reporting a beneficial ownership of 10.48% in Phibro Animal Health Corporation as of December 31, 2024.

Summary

• Brandes Investment Partners, L.P., CO-GP, LLC, Brandes Worldwide Holdings, L.P., and Glenn Carlson collectively reported beneficial ownership of 2,131,064 shares of Phibro Animal Health Corporation's Common Stock.
• This aggregate ownership represents 10.48% of the total outstanding shares of the class of securities.
• The reporting persons hold shared voting power over 1,330,724 shares and shared dispositive power over all 2,131,064 shares.
• The filing, an Amendment No. 1 to a Schedule 13G, certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake (10.48%) by Brandes Investment Partners may be viewed positively by other shareholders as it indicates confidence from a large investor, although the filing explicitly states the ownership is for ordinary course of business and not for control.

Key Dates

Keywords

Phibro Animal Health Corporation, Brandes Investment Partners, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Animal Health